GCK rs1799884 Polymorphism and Gestational Diabetes Mellitus: A System Review and Meta-Analysis

Background: The correlation among Glucokinase (GCK) rs1799884 polymorphism and the risk of gestational diabetes mellitus (GDM) remains controversial, as previous studies have reported inconsistent findings. The potential relationship among the GCK rs1799884 polymorphism and GDM risk was examined by...

Full description

Saved in:
Bibliographic Details
Main Authors: Yong Hu, Ao Wang, Ke Yi
Format: Article
Language:English
Published: IMR Press 2024-05-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/51/5/10.31083/j.ceog5105108
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850242292673150976
author Yong Hu
Ao Wang
Ke Yi
author_facet Yong Hu
Ao Wang
Ke Yi
author_sort Yong Hu
collection DOAJ
description Background: The correlation among Glucokinase (GCK) rs1799884 polymorphism and the risk of gestational diabetes mellitus (GDM) remains controversial, as previous studies have reported inconsistent findings. The potential relationship among the GCK rs1799884 polymorphism and GDM risk was examined by a meta-analysis. Methods: In order to find relevant studies for our investigation, we performed an extensive search across multiple databases, such as Ovid, PubMed, China National Knowledge Infrastructure, and Web of Science. Afterward, the link among the GDM risk and GCK rs1799884 polymorphism was evaluated by employing either random-effects models or fixed-effects to compute 95% confidence intervals (CIs) and pooled odds ratios (ORs). Results: This meta-analysis comprised a total of 11 studies. The findings revealed that the GCK rs1799884 polymorphism was linked to a decreased risk of GDM across all examined models. The pooled analysis demonstrated a substantial link, with the corresponding 95% CIs and the following ORs: Allele contrast: 0.80 (0.73–0.88), recessive model 0.81 (0.76–0.88), homozygote 0.60, (0.49–0.73), heterozygote 0.84, (0.78–0.91), dominant model 0.59, (0.48–0.72). Conclusions: The GCK rs1799884 variant, according to the current meta-analysis, may act as a genetic biomarker of GDM. The investigation was registered on PROSPERO (https://www.crd.york.ac.uk/prospero/) under registration number CRD42023492185.
format Article
id doaj-art-bcd05ac292fb4d8baaf78097aa3eaa6f
institution OA Journals
issn 0390-6663
language English
publishDate 2024-05-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj-art-bcd05ac292fb4d8baaf78097aa3eaa6f2025-08-20T02:00:18ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632024-05-0151510810.31083/j.ceog5105108S0390-6663(24)02376-5GCK rs1799884 Polymorphism and Gestational Diabetes Mellitus: A System Review and Meta-AnalysisYong Hu0Ao Wang1Ke Yi2Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second University Hospital, Sichuan University, 610041 Chengdu, Sichuan, ChinaKey Laboratory of Obstetrics & Gynecologic and Pediatric Diseases and Birth Defects of the Ministry of Education, West China Second University Hospital, Sichuan University, 610041 Chengdu, Sichuan, ChinaKey Laboratory of Obstetrics & Gynecologic and Pediatric Diseases and Birth Defects of the Ministry of Education, West China Second University Hospital, Sichuan University, 610041 Chengdu, Sichuan, ChinaBackground: The correlation among Glucokinase (GCK) rs1799884 polymorphism and the risk of gestational diabetes mellitus (GDM) remains controversial, as previous studies have reported inconsistent findings. The potential relationship among the GCK rs1799884 polymorphism and GDM risk was examined by a meta-analysis. Methods: In order to find relevant studies for our investigation, we performed an extensive search across multiple databases, such as Ovid, PubMed, China National Knowledge Infrastructure, and Web of Science. Afterward, the link among the GDM risk and GCK rs1799884 polymorphism was evaluated by employing either random-effects models or fixed-effects to compute 95% confidence intervals (CIs) and pooled odds ratios (ORs). Results: This meta-analysis comprised a total of 11 studies. The findings revealed that the GCK rs1799884 polymorphism was linked to a decreased risk of GDM across all examined models. The pooled analysis demonstrated a substantial link, with the corresponding 95% CIs and the following ORs: Allele contrast: 0.80 (0.73–0.88), recessive model 0.81 (0.76–0.88), homozygote 0.60, (0.49–0.73), heterozygote 0.84, (0.78–0.91), dominant model 0.59, (0.48–0.72). Conclusions: The GCK rs1799884 variant, according to the current meta-analysis, may act as a genetic biomarker of GDM. The investigation was registered on PROSPERO (https://www.crd.york.ac.uk/prospero/) under registration number CRD42023492185.https://www.imrpress.com/journal/CEOG/51/5/10.31083/j.ceog5105108gestational diabetes mellitusgckpolymorphismsmeta-analysis
spellingShingle Yong Hu
Ao Wang
Ke Yi
GCK rs1799884 Polymorphism and Gestational Diabetes Mellitus: A System Review and Meta-Analysis
Clinical and Experimental Obstetrics & Gynecology
gestational diabetes mellitus
gck
polymorphisms
meta-analysis
title GCK rs1799884 Polymorphism and Gestational Diabetes Mellitus: A System Review and Meta-Analysis
title_full GCK rs1799884 Polymorphism and Gestational Diabetes Mellitus: A System Review and Meta-Analysis
title_fullStr GCK rs1799884 Polymorphism and Gestational Diabetes Mellitus: A System Review and Meta-Analysis
title_full_unstemmed GCK rs1799884 Polymorphism and Gestational Diabetes Mellitus: A System Review and Meta-Analysis
title_short GCK rs1799884 Polymorphism and Gestational Diabetes Mellitus: A System Review and Meta-Analysis
title_sort gck rs1799884 polymorphism and gestational diabetes mellitus a system review and meta analysis
topic gestational diabetes mellitus
gck
polymorphisms
meta-analysis
url https://www.imrpress.com/journal/CEOG/51/5/10.31083/j.ceog5105108
work_keys_str_mv AT yonghu gckrs1799884polymorphismandgestationaldiabetesmellitusasystemreviewandmetaanalysis
AT aowang gckrs1799884polymorphismandgestationaldiabetesmellitusasystemreviewandmetaanalysis
AT keyi gckrs1799884polymorphismandgestationaldiabetesmellitusasystemreviewandmetaanalysis